Efficacy and safety of ipragliflozin as add-on to metformin for type 2 diabetes: a meta-analysis of double-blind randomized controlled trials.

CONCLUSION: Compared to metformin alone, ipragliflozin plus metformin significantly improved glycaemic control, reduced body weight and lowered blood pressure, However, further high-quality trials are required to determine their long-term efficacy and safety. PMID: 31414934 [PubMed - as supplied by publisher]
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research